基本信息
views: 363
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Alter co-discovered the Australia antigen, a key to detecting hepatitis B virus. Later, he spearheaded a project at the Clinical Center that created a storehouse of blood samples used to uncover the causes and reduce the risk of transfusion-associated hepatitis. He was principal investigator on studies that identified non-A, non-B hepatitis, now called hepatitis C. His work was instrumental in providing the scientific basis for instituting blood donor screening programs that have decreased the incidence of transfusion-transmitted hepatitis to near zero. In 2013 he received the Canada Gairdner International Award, given to a scientist whose advances have had, or will potentially have, a significant impact on health outcomes in the developing world. Alter continues to study the infectious risks of blood transfusion, but now focuses on agents other than hepatitis viruses. In addition, he continues to study the natural history and outcomes of hepatitis C virus infection.
Research Interests
Papers共 470 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
HEPATOLOGY (2023): S1973-S1974
Cited0Views0Bibtex
0
0
Journal of translational medicineno. 1 (2023): 1-16
The lancet. Gastroenterology & hepatologyno. 11 (2023): 967-969
iScience (2022)
medRxiv : the preprint server for health sciences (2022)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn